C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Inclusion Criteria: * Able to provide signed and dated informed consent * Males and females between 18 - 75 years old inclusive * Documented history of first recurrent Clostridioides difficile (former Clostridium difficile) infection (rCDI), confirmed by a positive C. difficile test (Toxin A+B positive or Toxin B only), with initial infection occurring within the previous 12-months. * Must, in accordance with standard of care practices, have completed a SOC oral antibiotic therapy for the first rCDI no more than 5 days prior to the date of enrolment (baseline visit- Day 0). * Must not have any CDI-related symptoms when enrolled in the study at baseline (Day 0). Exclusion Criteria: * Current episode of CDI or delayed symptom resolution from previous recurrence, according to the physical exam and investigator assessment * Toxin A positive, and Toxin B negative C. difficile test. * Planned CDI recurrence treatment for the duration of the study e.g., fecal microbiome transplant, probiotics, Live Biotherapeutic Products (LBPs) * Those who are on further antibiotic treatment following initial rCDI antibiotic therapy completion. * Pregnant or lactating women or women who intend to become pregnant within the next 3 months. * Subjects presenting with active diarrhoea (3 or more stools per 24-hour period) and within Bristol stool scale range of 5-7 at baseline. * Has any significant acute or chronic coexisting health conditions that would prevent them from fulfilling the study requi…